New guidelines on acute otitis media: An overview of their key principles for practice

Article Type
Changed
Tue, 10/23/2018 - 08:38
Display Headline
New guidelines on acute otitis media: An overview of their key principles for practice
Article PDF
Author and Disclosure Information

S. Michael Marcy, MD
Clinical Professor of Pediatrics, University of Southern California and University of California, Los Angeles, Schools of Medicine, Los Angeles, and Kaiser Foundation Hospital, Panorama City, Calif.; Consultant, American Academy of Pediatrics Subcommittee on Management of Acute Otitis Media

S. Michael Marcy, MD, reported that he serves as a consultant to the Abbott and GlaxoSmithKline corporations. He also reported that he discusses off-label uses of therapies.

Publications
Page Number
S3-S9
Author and Disclosure Information

S. Michael Marcy, MD
Clinical Professor of Pediatrics, University of Southern California and University of California, Los Angeles, Schools of Medicine, Los Angeles, and Kaiser Foundation Hospital, Panorama City, Calif.; Consultant, American Academy of Pediatrics Subcommittee on Management of Acute Otitis Media

S. Michael Marcy, MD, reported that he serves as a consultant to the Abbott and GlaxoSmithKline corporations. He also reported that he discusses off-label uses of therapies.

Author and Disclosure Information

S. Michael Marcy, MD
Clinical Professor of Pediatrics, University of Southern California and University of California, Los Angeles, Schools of Medicine, Los Angeles, and Kaiser Foundation Hospital, Panorama City, Calif.; Consultant, American Academy of Pediatrics Subcommittee on Management of Acute Otitis Media

S. Michael Marcy, MD, reported that he serves as a consultant to the Abbott and GlaxoSmithKline corporations. He also reported that he discusses off-label uses of therapies.

Article PDF
Article PDF
Related Articles
Page Number
S3-S9
Page Number
S3-S9
Publications
Publications
Article Type
Display Headline
New guidelines on acute otitis media: An overview of their key principles for practice
Display Headline
New guidelines on acute otitis media: An overview of their key principles for practice
Citation Override
Cleveland Clinic Journal of Medicine 2004 June;71(suppl 4):S3-S9
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

From principles to practice: Case-based applications of the acute otitis media guidelines

Article Type
Changed
Tue, 10/23/2018 - 08:38
Display Headline
From principles to practice: Case-based applications of the acute otitis media guidelines
Article PDF
Author and Disclosure Information

Camille Sabella, MD
Staff, Section of Pediatric Infectious Diseases, The Children’s Hospital, Cleveland Clinic Foundation; Associate Professor of Pediatrics, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio

Johanna Goldfarb, MD
Section Head, Pediatric Infectious Diseases, The Children’s Hospital, Cleveland Clinic Foundation, Cleveland, Ohio

Scott Francy, MD
Staff, Department of General Pediatrics, The Children’s Hospital, Cleveland Clinic Foundation, Cleveland, Ohio

Jennifer K. Long, PharmD
Infectious Diseases Clinical Pharmacy Specialist, Department of Pharmacy, Cleveland Clinic Foundation, Cleveland, Ohio

S. Michael Marcy, MD
Clinical Professor of Pediatrics, University of Southern California and University of California, Los Angeles, Schools of Medicine, Los Angeles, and Kaiser Foundation Hospital, Panorama City, Calif.; Consultant, American Academy of Pediatrics Subcommittee on Management of Acute Otitis Media

Jennifer K. Long, PharmD, reported that she is on the speakers’ bureaus of the Bayer and Pfizer corporations.

S. Michael Marcy, MD, reported that he serves as a consultant to the Abbott and GlaxoSmithKline corporations. He also reported that he discusses off-label uses of therapies.

Scott Francy, MD, Johanna Goldfarb, MD, and Camille Sabella, MD, reported no relationships that could be perceived as a conflict of interest.

Publications
Page Number
S10-S18
Author and Disclosure Information

Camille Sabella, MD
Staff, Section of Pediatric Infectious Diseases, The Children’s Hospital, Cleveland Clinic Foundation; Associate Professor of Pediatrics, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio

Johanna Goldfarb, MD
Section Head, Pediatric Infectious Diseases, The Children’s Hospital, Cleveland Clinic Foundation, Cleveland, Ohio

Scott Francy, MD
Staff, Department of General Pediatrics, The Children’s Hospital, Cleveland Clinic Foundation, Cleveland, Ohio

Jennifer K. Long, PharmD
Infectious Diseases Clinical Pharmacy Specialist, Department of Pharmacy, Cleveland Clinic Foundation, Cleveland, Ohio

S. Michael Marcy, MD
Clinical Professor of Pediatrics, University of Southern California and University of California, Los Angeles, Schools of Medicine, Los Angeles, and Kaiser Foundation Hospital, Panorama City, Calif.; Consultant, American Academy of Pediatrics Subcommittee on Management of Acute Otitis Media

Jennifer K. Long, PharmD, reported that she is on the speakers’ bureaus of the Bayer and Pfizer corporations.

S. Michael Marcy, MD, reported that he serves as a consultant to the Abbott and GlaxoSmithKline corporations. He also reported that he discusses off-label uses of therapies.

Scott Francy, MD, Johanna Goldfarb, MD, and Camille Sabella, MD, reported no relationships that could be perceived as a conflict of interest.

Author and Disclosure Information

Camille Sabella, MD
Staff, Section of Pediatric Infectious Diseases, The Children’s Hospital, Cleveland Clinic Foundation; Associate Professor of Pediatrics, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio

Johanna Goldfarb, MD
Section Head, Pediatric Infectious Diseases, The Children’s Hospital, Cleveland Clinic Foundation, Cleveland, Ohio

Scott Francy, MD
Staff, Department of General Pediatrics, The Children’s Hospital, Cleveland Clinic Foundation, Cleveland, Ohio

Jennifer K. Long, PharmD
Infectious Diseases Clinical Pharmacy Specialist, Department of Pharmacy, Cleveland Clinic Foundation, Cleveland, Ohio

S. Michael Marcy, MD
Clinical Professor of Pediatrics, University of Southern California and University of California, Los Angeles, Schools of Medicine, Los Angeles, and Kaiser Foundation Hospital, Panorama City, Calif.; Consultant, American Academy of Pediatrics Subcommittee on Management of Acute Otitis Media

Jennifer K. Long, PharmD, reported that she is on the speakers’ bureaus of the Bayer and Pfizer corporations.

S. Michael Marcy, MD, reported that he serves as a consultant to the Abbott and GlaxoSmithKline corporations. He also reported that he discusses off-label uses of therapies.

Scott Francy, MD, Johanna Goldfarb, MD, and Camille Sabella, MD, reported no relationships that could be perceived as a conflict of interest.

Article PDF
Article PDF
Related Articles
Page Number
S10-S18
Page Number
S10-S18
Publications
Publications
Article Type
Display Headline
From principles to practice: Case-based applications of the acute otitis media guidelines
Display Headline
From principles to practice: Case-based applications of the acute otitis media guidelines
Citation Override
Cleveland Clinic Journal of Medicine 2004 June;71(suppl 4):S10-S18
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media